INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA
INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA
INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CAPÍTULO IV<br />
116<br />
TABLE 3. Clinical characteristics of high and low sRAGE patients groups<br />
Variables<br />
Low sRAGE<br />
(1220 pg/mL)<br />
(n = 30)<br />
p value<br />
DEMOGRAPHIC FACTORS<br />
Age (years) 68.9 ± 1.4 71.30 ± 1.8 0.370<br />
Sex (male/female) 67.1 % / 32.9 % 63.3 % / 36.7 % 0.712<br />
Medium blood pressure (mmHg) 94.6 ± 1.7 93.9 ± 2.7 0.815<br />
IMC (kg/m 2 ) 28.5 ± 0.6 27.4 ± 1.2 0.360<br />
CARDIOVASCULAR RISK FACTORS<br />
Arterial Hypertension 65.8 % 60.0 % 0.580<br />
Hyperlipidemia 62.5 % 56.7 % 0.582<br />
Diabetes mellitus 35.6 % 36.7 % 0.920<br />
Smokers 8.2 % 6.7 %<br />
Ex-smokers 34.2 % 26.7 %<br />
ISCHEMIC ETIOLOGY AND SEVERITY<br />
0.690<br />
Ischemic 21.9 % 50.0 % 0.005<br />
One damaged vessel<br />
Two damaged vessels<br />
Three damaged vessels<br />
NYHA I<br />
NYHA II<br />
NYHA III<br />
68.8 %<br />
18.8 %<br />
12.5 %<br />
FUNCTIONAL CLASS (NYHA)<br />
17.4 %<br />
66.7 %<br />
15.9 %<br />
6.70 %<br />
53.3 %<br />
40.0 %<br />
3.3 %<br />
63.3 %<br />
33.3 %<br />
0.002<br />
0.046<br />
EKG<br />
Rhythm (sinusal/non) 70.8 % / 29.2 % 33.3 % / 66.7 % 0.001<br />
ECHOCARDIOGRAPHY<br />
Depressed LVEF 77.5 % 72.4 % 0.592<br />
Left ventricular hipertrophy 52.5 % 44.4 % 0.322<br />
Left ventricular dilatation 60.3 % 66.7 % 0.643<br />
Left atrial dilatation 84.4 % 100 % 0.029<br />
ANALITIC PARAMETERS<br />
Glucose (mg/dL) 116.6 ± 3.6 133.6 ± 12.0 0.185<br />
Fructosamine (mg/dL) 248.5 ± 14.4 289.9 ± 16.9 0.106<br />
Glycated haemoglobin (%) 6.5 ± 0.2 7.0 ± 0.3 0.178<br />
Glycated albumin (ng/mL) 21.3 ± 1.5 21.25 ± 1.84 0.964<br />
Fluorescent AGEs (AU) 63.1 ± 2.3 71.52 ± 3.97 0.061<br />
Haemoglobin (g/dL) 13.5 ± 0.2 12.5 ± 0.23 0.002<br />
Creatinine (mg/dL) 1.10 ± 0.03 1.18 ± 0.06 0.179<br />
Estimated glomerular filtrate (ml/min) 61.51 ± 2.15 52.50 ± 2.77 0.054<br />
Cystatine (mg/L) 0.98 ± 0.05 1.19 ± 0.10 0.020<br />
NTproBNP > 400 pg/mL 75.4% 100% 0.009<br />
LDL (mg/dL) 112.83 ± 3.73 108.53 ± 8.05 0.581<br />
HDL (mg/dL) 44.63 ± 2.42 43.18 ± 3.34 0.738<br />
Triglicerides (mg/dL) 120.01 ± 7.57 104.32 ± 10.80 0.262<br />
TREATMENT<br />
B-blockers 89.0 % 80.0 % 0.224<br />
ACE inhibitors/ARA 93.2 % 96.7 % 0.778<br />
Espironolactone 61.6 % 70.0 % 0.422<br />
Diuretics 79.5 % 83.3 % 0.218<br />
Antiplatelets 46.6 % 30.0 % 0.618<br />
Nitrates 12.2 % 26.7 % 0.075<br />
Statins 45.2 % 50.0 % 0.658<br />
Oral antidiabetic drugs 28.8 % 20.0 % 0.358<br />
Insulin 6.8 % 16.7 % 0.126<br />
Abbreviations as in Table 1